The Clinical and Laboratory Response to Recombinant Factor VIIa in Trauma and Surgical Patients with Acquired Coagulopathy
- 31 August 2006
- journal article
- Published by Elsevier in Current Surgery
- Vol. 63 (4) , 246-251
- https://doi.org/10.1016/j.cursur.2006.03.007
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt traumaInjury, 2005
- Factor VIIa for Correction of Traumatic CoagulopathyPublished by Wolters Kluwer Health ,2004
- RECOMBINANT FACTOR VIIa INCREASES THE PRESSURE AT WHICH REBLEEDING OCCURS IN PORCINE UNCONTROLLED AORTIC HEMORRHAGE MODELShock, 2004
- Early Coagulopathy Predicts Mortality in TraumaPublished by Wolters Kluwer Health ,2003
- Recombinant factor viia for control of hemorrhage: early experience in critically ill trauma patientsJournal of Clinical Anesthesia, 2003
- Early Injection of High-Dose Recombinant Factor VIIa Decreases Blood Loss and Prolongs Time from Injury to Death in Experimental Liver InjuryPublished by Wolters Kluwer Health ,2002
- The Effect of Recombinant Factor VIIa on Coagulopathic Pigs with Grade V Liver InjuriesPublished by Wolters Kluwer Health ,2002
- Early Use of Recombinant Factor VIIa Improves Mean Arterial Pressure and May Potentially Decrease Mortality in Experimental Hemorrhagic Shock: A Pilot StudyPublished by Wolters Kluwer Health ,2002
- Intravenous rFVIIa Administered for Hemorrhage Control in Hypothermic Coagulopathic Swine with Grade V Liver InjuriesThe Journal of Trauma: Injury, Infection, and Critical Care, 2001
- Treatment of traumatic bleeding with recombinant factor VIIaThe Lancet, 1999